Back to Search
Start Over
Additional file 2 of Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
- Publisher :
- figshare
-
Abstract
- Additional file 2: Supplementary Table 2. The informed consent form used for ImmunoSABR phase 2 trial.
- Subjects :
- 3. Good health
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi...........957e663bd75eb138bfda916c9b4537cd